SCHEMBL5772766

SCHEMBL5772766

CCCCCCCCCCCCCCCC(=O)C1CC(=O)NC1=O

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
PRKCA P17252 1/20 0.46
NAAA Q02083 4/20 0.43
HSD17B10 Q99714 1/20 0.41
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 1/20 0.39
CCR2 P41597 1/20 0.39
FAAH O00519 1/20 0.39
POLB P06746 1/20 0.39
CES2 O00748 3/20 0.38
CES1 P23141 3/20 0.38
TSHR P16473 1/20 0.37
SLC22A6 Q4U2R8 1/20 0.37
SLC22A8 Q8TCC7 1/20 0.37
GPR84 Q9NQS5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL290653 1.00 LMNA (0.50) LMNAPRKCANAAAHSD17B10ALDH1A1
SCHEMBL8610844 1.00 LMNA (0.50) LMNAPRKCANAAAHSD17B10ALDH1A1
SCHEMBL6687040 1.00 LMNA (0.50) LMNAPRKCANAAAHSD17B10ALDH1A1
SCHEMBL2100563 0.98 LMNA (0.51) LMNAPRKCANAAAHSD17B10ALDH1A1
SCHEMBL20955943 0.92 TERT (0.46) LMNAHSD17B10FAAHPOLB
SCHEMBL734672 0.92 TERT (0.46) LMNAHSD17B10FAAHPOLB
SCHEMBL8178098 0.86 HSD17B10 (0.55) LMNANAAAHSD17B10ALDH1A1L3MBTL1
SCHEMBL5617229 0.83 ALDH1A1 (0.40) LMNAPRKCANAAAHSD17B10ALDH1A1
SCHEMBL27359133 0.79 HSD17B10 (0.40) LMNAHSD17B10ALDH1A1L3MBTL1NPC1
Ethylamine SCHEMBL6565299 0.79 ALDH1A1 (0.38) LMNAPRKCANAAAALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105152979-A Preparation method of Na-Fmoc(fluorenylmethoxycarbonyl)-Lys(Palmitoyl)-OH GL BIOCHEM SHANGHAI LTD 2015-12-16 CN claimed
CN-105152979-A Preparation method of Na-Fmoc(fluorenylmethoxycarbonyl)-Lys(Palmitoyl)-OH GL BIOCHEM SHANGHAI LTD 2015-12-16 CN disclosed
CN-105152979-A Preparation method of Na-Fmoc(fluorenylmethoxycarbonyl)-Lys(Palmitoyl)-OH GL BIOCHEM SHANGHAI LTD 2015-12-16 CN disclosed
US-20060116331-A1 Glycosylceramide analogues BIOMIRA, INC. (CA) 2006-06-01 US disclosed
EP-1572114-A2 GLYCOSYLCERAMIDE ANALOGUES BIOMIRA, INC. (CA) 2005-09-14 EP disclosed
WO-2004028475-A2 GLYCOSYLCERAMIDE ANALOGUES BIOMIRA, INC. (CA) 2004-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060116331-A1 Glycosylceramide analogues UGCG, ASAH2, GBA2 LMNA 4092/4885PRKCA 3761/4885NAAA 504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.